-
1
-
-
0347453124
-
-
World Health Organization (WHO). World Health Organization 2003: Geneva, Switzerland
-
World Health Organization (WHO). World Health Report 2003 - Shaping the future. World Health Organization 2003: Geneva, Switzerland, 2003
-
(2003)
World Health Report 2003 - Shaping the Future
-
-
-
3
-
-
19344364960
-
-
American Heart Association. Dallas, TX: American Heart Association
-
American Heart Association. Heart Disease and Stroke Statistics - 2009 Update. Dallas, TX: American Heart Association, 2009
-
(2009)
Heart Disease and Stroke Statistics - 2009 Update
-
-
-
4
-
-
23944481875
-
Guidelines on cardiovascular disease prevention in clinical practice: The European perspective
-
DOI 10.1097/01.hco.0000176405.56119.54
-
Graham IM. Guidelines on cardiovascular disease prevention in clinical practice: the European perspective. Curr Opin Cardiol 2005;20:430-439 (Pubitemid 41192160)
-
(2005)
Current Opinion in Cardiology
, vol.20
, Issue.5
, pp. 430-439
-
-
Graham, I.M.1
-
5
-
-
0035897696
-
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
6
-
-
34548329882
-
European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice
-
Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 2007;14:S1-113
-
(2007)
Eur J Cardiovasc Prev Rehabil
, vol.14
-
-
Graham, I.1
Atar, D.2
Borch-Johnsen, K.3
-
7
-
-
0037417947
-
American Heart Association guide for improving cardiovascular health at the community level: A statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science
-
Pearson TA, Bazzarre TL, Daniels SR, et al. American Heart Association guide for improving cardiovascular health at the community level: a statement for public health practitioners, healthcare providers, and health policy makers from the American Heart Association Expert Panel on Population and Prevention Science. Circulation 2003;107:645-651
-
(2003)
Circulation
, vol.107
, pp. 645-651
-
-
Pearson, T.A.1
Bazzarre, T.L.2
Daniels, S.R.3
-
8
-
-
0037118660
-
AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 Update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases
-
Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 Update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. Circulation 2002;106:388-391
-
(2002)
Circulation
, vol.106
, pp. 388-391
-
-
Pearson, T.A.1
Blair, S.N.2
Daniels, S.R.3
-
9
-
-
0038460302
-
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report
-
DOI 10.1001/jama.289.19.2560
-
Chobanian A, Bakris G, Black H, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. JAMA 2003;289:2560-2572 (Pubitemid 37430158)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.19
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
10
-
-
0035949527
-
AHA/ACC Scientific Statement: AHA/ ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
-
Smith Jr SC, Blair SN, Bonow RO, et al. AHA/ACC Scientific Statement: AHA/ ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 2001;104:1577-1579
-
(2001)
Circulation
, vol.104
, pp. 1577-1579
-
-
Smith Jr., S.C.1
Blair, S.N.2
Bonow, R.O.3
-
12
-
-
4544275379
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
-
Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004;44:720-732
-
(2004)
J Am Coll Cardiol
, vol.44
, pp. 720-732
-
-
Grundy, S.M.1
Cleeman, J.I.2
Merz, C.N.3
-
13
-
-
34248223741
-
Safety of rosuvastatin: Update on 16,876 rosuvastatin-treated patients in a multinational clinical trial program
-
DOI 10.1159/000100908
-
Shepherd J, Vidt DG, Miller E, et al. Safety of rosuvastatin: update of 16,876 rosuvastatin-treated patients in a multinational clinical trial program. Cardiology 2007;107:433-443 (Pubitemid 46788271)
-
(2007)
Cardiology
, vol.107
, Issue.4
, pp. 433-443
-
-
Shepherd, J.1
Vidt, D.G.2
Miller, E.3
Harris, S.4
Blasetto, J.5
-
14
-
-
0038645309
-
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR trial)
-
DOI 10.1016/S0002-9149(03)00530-7
-
Jones PH, Davidson MH, Stein EA, et al. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial). Am J Cardiol 2003;92:152-160 (Pubitemid 36835963)
-
(2003)
American Journal of Cardiology
, vol.92
, Issue.2
, pp. 152-160
-
-
Jones, P.H.1
Davidson, M.H.2
Stein, E.A.3
Bays, H.E.4
McKenney, J.M.5
Miller, E.6
Cain, V.A.7
Blasetto, J.W.8
-
15
-
-
0036910821
-
Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial
-
DOI 10.1067/mhj.2002.129312
-
Brown WV, Bays HE, Hassman DR, et al. Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: a randomized, double-blind, 52-week trial. Am Heart J 2002;144:1036-1043 (Pubitemid 36026917)
-
(2002)
American Heart Journal
, vol.144
, Issue.6
, pp. 1036-1043
-
-
Brown, W.V.1
Bays, H.E.2
Hassman, D.R.3
McKenney, J.4
Chitra, R.5
Hutchinson, H.6
Miller, E.7
-
16
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
-
17
-
-
26844548012
-
Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: Results from the URANUS study
-
and the URANUS study investigators
-
Berne C, Siewert-Delle A, and the URANUS study investigators. Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study. Cardiovasc Diabetol 2005;4:7
-
(2005)
Cardiovasc Diabetol
, vol.4
, pp. 7
-
-
Berne, C.1
Siewert-Delle, A.2
-
18
-
-
34848817975
-
Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined c-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (<70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study)
-
Betteridge DJ, Gibson JM, Sager PT. Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined c-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (<70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study). Am J Cardiol 2007;100:1245-1248
-
(2007)
Am J Cardiol
, vol.100
, pp. 1245-1248
-
-
Betteridge, D.J.1
Gibson, J.M.2
Sager, P.T.3
-
19
-
-
20144370402
-
Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes - CORALL study
-
Vincent HH on behalf of the Dutch CORALL Study Group
-
Wolffenbuttel BHR, Franken AAM, Vincent HH on behalf of the Dutch CORALL Study Group. Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes - CORALL study. J Int Med 2005;257:531-539
-
(2005)
J Int Med
, vol.257
, pp. 531-539
-
-
Wolffenbuttel, B.H.R.1
Franken, A.A.M.2
-
20
-
-
4344630666
-
-
Wilmington, DE: AstraZeneca Pharmaceuticals LP
-
Crestor [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals LP, 2003
-
(2003)
Crestor [Package Insert]
-
-
-
21
-
-
33644546619
-
-
New York, NY: Pfizer Inc
-
Lipitor [package insert]. New York, NY: Pfizer Inc, 2004
-
(2004)
Lipitor [Package Insert]
-
-
-
22
-
-
13644265047
-
-
Whitehouse Station, NJ: Merck & Co, Inc
-
Zocor [package insert]. Whitehouse Station, NJ: Merck & Co, Inc, 2004
-
(2004)
Zocor [Package Insert]
-
-
-
23
-
-
33644558287
-
-
Princeton, NJ: Bristol-Myers Squibb Co
-
Pravachol [package insert]. Princeton, NJ: Bristol-Myers Squibb Co, 2004
-
(2004)
Pravachol [Package Insert]
-
-
-
24
-
-
13644249346
-
-
East Hanover, NJ: Novartis Pharmaceuticals
-
Lescol [package insert]. East Hanover, NJ: Novartis Pharmaceuticals, 2003
-
(2003)
Lescol [Package Insert]
-
-
-
25
-
-
63749103497
-
-
Whitehouse Station, NJ: Merck & Co, Inc
-
Mevacor [package insert]. Whitehouse Station, NJ: Merck & Co, Inc, 2004
-
(2004)
Mevacor [Package Insert]
-
-
-
26
-
-
36549040492
-
In defense of pharmacoepidemiology - Embracing the yin and yang of drug research
-
Avorn J. In defense of pharmacoepidemiology - embracing the yin and yang of drug research. N Engl J Med 2007;357:2219-2221
-
(2007)
N Engl J Med
, vol.357
, pp. 2219-2221
-
-
Avorn, J.1
-
27
-
-
33845257814
-
Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice
-
Ohsfeldt RL, Gandhi SK, Fox KM, et al. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. Am J Manag Care 2006;12:S412-23
-
(2006)
Am J Manag Care
, vol.12
-
-
Ohsfeldt, R.L.1
Gandhi, S.K.2
Fox, K.M.3
-
28
-
-
34249098742
-
Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals
-
Kamat SA, Gandhi SK, Davidson MH. Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals. Curr Med Res Opin 2007;23:1121-1130
-
(2007)
Curr Med Res Opin
, vol.23
, pp. 1121-1130
-
-
Kamat, S.A.1
Gandhi, S.K.2
Davidson, M.H.3
-
29
-
-
33846700143
-
Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting
-
DOI 10.2146/060104
-
Bullano MF, Kamat S, Wertz DA, et al. Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density lipoprotein cholesterol goals in a usual care setting. Am J Health Syst Pharm 2007;64:276-284 (Pubitemid 46193258)
-
(2007)
American Journal of Health-System Pharmacy
, vol.64
, Issue.3
, pp. 276-284
-
-
Bullano, M.F.1
Kamat, S.2
Wertz, D.A.3
Borok, G.M.4
Gandhi, S.K.5
McDonough, K.L.6
Willey, V.J.7
-
30
-
-
33645682109
-
Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting
-
Bullano MF, Wertz DA, Yang GW, et al. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting. Pharmacotherapy 2006;26:469-478
-
(2006)
Pharmacotherapy
, vol.26
, pp. 469-478
-
-
Bullano, M.F.1
Wertz, D.A.2
Yang, G.W.3
-
31
-
-
50149117208
-
LDL-C reductions and goal attainment among naïve statin users in the Netherlands: Real life results
-
Heintjes EM, Hirsch MW, Linden M, et al. LDL-C reductions and goal attainment among naïve statin users in the Netherlands: real life results. Curr Med Res Opin 2008;24:2241-2250
-
(2008)
Curr Med Res Opin
, vol.24
, pp. 2241-2250
-
-
Heintjes, E.M.1
Hirsch, M.W.2
Linden, M.3
-
32
-
-
43749113805
-
The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal
-
DOI 10.1111/j.1742-1241.2008.01771.x
-
Harley CR, Gandhi S, Heien H, et al. The comparative effectiveness of rosuvastatin vs. other statins in patients with an increased risk of failure to reach NCEP ATP III goal. Int J Clin Pract 2008;62:889-895 (Pubitemid 351691501)
-
(2008)
International Journal of Clinical Practice
, vol.62
, Issue.6
, pp. 889-895
-
-
Harley, C.R.1
Gandhi, S.2
Heien, H.3
Nelson, S.P.4
-
33
-
-
53749086313
-
Statin cost-effectiveness comparisons using real-world effectiveness data: Formulary implications
-
Ohsfeldt RL, Gandhi SK, Fox KM, et al. Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications. Value Health 2008;11:1061-1069
-
(2008)
Value Health
, vol.11
, pp. 1061-1069
-
-
Ohsfeldt, R.L.1
Gandhi, S.K.2
Fox, K.M.3
-
34
-
-
42049121865
-
A UK survey of rosuvastatin in general practice: Reaching cholesterol targets
-
1008
-
Kassianos G, Reckless J, Emmas C, et al. A UK survey of rosuvastatin in general practice: reaching cholesterol targets. Br J Cardiol 1008;15:95-100
-
Br J Cardiol
, vol.15
, pp. 95-100
-
-
Kassianos, G.1
Reckless, J.2
Emmas, C.3
-
35
-
-
41149180129
-
Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance
-
Backes JM, Venero CV, Gibson CA, et al. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance. Ann Pharmacother 2008;42:341-346
-
(2008)
Ann Pharmacother
, vol.42
, pp. 341-346
-
-
Backes, J.M.1
Venero, C.V.2
Gibson, C.A.3
-
36
-
-
34548617373
-
Effectiveness of statins in Medicare-eligible patients and patients565 years using clinical practice data
-
Fox KM, Gandhi SK, Ohsfeldt RL, et al. Effectiveness of statins in Medicare-eligible patients and patients565 years using clinical practice data. Int J Clin Pract 2007;61:1634-1642
-
(2007)
Int J Clin Pract
, vol.61
, pp. 1634-1642
-
-
Fox, K.M.1
Gandhi, S.K.2
Ohsfeldt, R.L.3
-
37
-
-
36048959846
-
Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: A retrospective study using an electronic medical records dataset in the United States
-
Fox KM, Gandhi SK, Ohsfeldt RL, et al. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. Cur Med Res Opin 2007;23:2125-2133
-
(2007)
Cur Med Res Opin
, vol.23
, pp. 2125-2133
-
-
Fox, K.M.1
Gandhi, S.K.2
Ohsfeldt, R.L.3
-
38
-
-
37849044165
-
Comparison of low density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in real-world clinical practice setting
-
Fox KM, Gandhi SK, Ohsfeldt RL, et al. Comparison of low density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in real-world clinical practice setting. Am J Manag Care 2007;13:S270-5
-
(2007)
Am J Manag Care
, vol.13
-
-
Fox, K.M.1
Gandhi, S.K.2
Ohsfeldt, R.L.3
-
39
-
-
35848948801
-
Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice
-
Harley CR, Gandhi S, Blasetto J, et al. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Am J Geriatr Pharmacother 2007;5:185-194
-
(2007)
Am J Geriatr Pharmacother
, vol.5
, pp. 185-194
-
-
Harley, C.R.1
Gandhi, S.2
Blasetto, J.3
-
40
-
-
41949105051
-
Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: Rosuvastatin compared with other statins in usual care
-
DOI 10.1517/14656566.9.5.669
-
Harley CR, Gandhi SK, Heien H, et al. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother 2008;9:669-676 (Pubitemid 351566187)
-
(2008)
Expert Opinion on Pharmacotherapy
, vol.9
, Issue.5
, pp. 669-676
-
-
Harley, C.R.1
Gandhi, S.K.2
Heien, H.3
McDonough, K.4
Nelson, S.P.5
-
42
-
-
37349030074
-
Titration patterns with rosuvastatin as compared with other statins in clinical practice: A retrospective observational cohort study using an electronic medical record database
-
Fox KM, Gandhi SK, Ohsfeldt RL, et al. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. Clin Ther 2007;29:2385-2394
-
(2007)
Clin Ther
, vol.29
, pp. 2385-2394
-
-
Fox, K.M.1
Gandhi, S.K.2
Ohsfeldt, R.L.3
-
43
-
-
0036917270
-
Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice
-
DOI 10.1016/S0002-9343(02)01303-7, PII S0002934302013037
-
Frolkis JP, Pearce GL, Nambi V, et al. Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice. Am J Med 2002;113:625-629 (Pubitemid 36015797)
-
(2002)
American Journal of Medicine
, vol.113
, Issue.8
, pp. 625-629
-
-
Frolkis, J.P.1
Pearce, G.L.2
Nambi, V.3
Minor, S.4
Sprecher, D.L.5
|